Suppr超能文献

用于指导手术可切除性和预后的PCC分期系统的利弊。

The pros and cons of the PCC staging system to guide surgical resectability and prognosis.

作者信息

Liu Pei, Song Yinghui, Shakoor Kashif, Peng Chuang, Liu Sulai

机构信息

Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University; Changsha 410005, China.

Central Laboratory of Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R. China.

出版信息

J Cancer. 2022 Oct 9;13(13):3444-3451. doi: 10.7150/jca.76696. eCollection 2022.

Abstract

Perihilar cholangiocarcinoma (PCC) is a malignant mass originating from the bile ducts. There is currently no unified treatment plan, and there are various treatment methods applied in clinical practice, as well as several different staging and typing systems to guide resectability, prognosis and survival prediction. The choice of treatment for PCC is closely related to the stage of the tumor. Accurate preoperative staging is necessary for correct resectability assessment and the selection of a reasonable treatment plan and surgical method; similarly, accurate postoperative pathological staging is necessary to guide further treatment and judgment of the patient's prognosis. A universally accepted staging system facilitates the comparison of cases between different centers, but there is much debate about the classification and staging of PCC. At present, the existing staging systems include the Bismuth-Corlette classification, AJCC/UICC TNM staging, modified T staging, Gazzaniga staging, JSBS staging, and Mayo staging. Each system has advantages, but there is no comprehensive guide for tumor resectability, prognosis, and survival. In this paper, the pros and cons of the different systems for staging PCC in terms of resectability, prognosis and survival prediction are discussed.

摘要

肝门部胆管癌(PCC)是一种起源于胆管的恶性肿瘤。目前尚无统一的治疗方案,临床实践中应用的治疗方法多种多样,还有几种不同的分期和分型系统用于指导可切除性、预后及生存预测。PCC的治疗选择与肿瘤分期密切相关。准确的术前分期对于正确评估可切除性、选择合理的治疗方案和手术方法至关重要;同样,准确的术后病理分期对于指导进一步治疗和判断患者预后也很有必要。一个被普遍接受的分期系统有助于不同中心之间病例的比较,但关于PCC的分类和分期存在很多争议。目前,现有的分期系统包括Bismuth-Corlette分类、AJCC/UICC TNM分期、改良T分期、Gazzaniga分期、JSBS分期和Mayo分期。每个系统都有优点,但对于肿瘤的可切除性、预后及生存情况均缺乏全面的指导。本文讨论了不同PCC分期系统在可切除性、预后及生存预测方面的优缺点。

相似文献

7
Staging of extrahepatic cholangiocarcinoma.肝外胆管癌的分期
Eur Radiol. 2008 Oct;18(10):2182-95. doi: 10.1007/s00330-008-1006-x. Epub 2008 May 6.

本文引用的文献

1
The new insight of treatment in Cholangiocarcinoma.胆管癌治疗的新见解。
J Cancer. 2022 Jan 1;13(2):450-464. doi: 10.7150/jca.68264. eCollection 2022.
2
Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review.胆道癌治疗的前沿进展:一项最新综述
J Clin Transl Hepatol. 2021 Aug 28;9(4):559-567. doi: 10.14218/JCTH.2021.00007. Epub 2021 May 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验